{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:39:55Z","timestamp":1785886795212,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05651-z","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T02:01:26Z","timestamp":1719280886000},"page":"1749-1756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Managing rheumatoid arthritis and cardiovascular disease: the role of physical medicine and rehabilitation"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6459-398X","authenticated-orcid":false,"given":"Zhaxybek","family":"Sagtaganov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-6918","authenticated-orcid":false,"given":"Marlen","family":"Yessirkepov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9651-7295","authenticated-orcid":false,"given":"Dana","family":"Bekaryssova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darkhan","family":"Suigenbayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"5651_CR1","unstructured":"Medical Subject Headings Thesaurus (MeSH) https:\/\/www.ncbi.nlm.nih.gov\/mesh\/?term=cardiovascular+diseases (Accessed 21 February 2024)"},{"key":"5651_CR2","unstructured":"WHO (2024) https:\/\/www.who.int\/health-topics\/cardiovascular-diseases#tab=tab_1 (Accessed 21"},{"key":"5651_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11926-012-0271-5","volume":"14","author":"C Charles-Schoeman","year":"2012","unstructured":"Charles-Schoeman C (2012) Cardiovascular disease and rheumatoid arthritis: an update. Curr Rheumatol Rep 14:455\u2013462. https:\/\/doi.org\/10.1007\/s11926-012-0271-5","journal-title":"Curr Rheumatol Rep"},{"key":"5651_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.cir.0000054612.26458.b2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303\u20131307. https:\/\/doi.org\/10.1161\/01.cir.0000054612.26458.b2","journal-title":"Circulation"},{"key":"5651_CR5","unstructured":"Medical Subject Headings Thesaurus (MeSH) https:\/\/www.ncbi.nlm.nih.gov\/mesh\/?term=arthritis%2C+rheumatoid (Accessed 21 February 2024)"},{"key":"5651_CR6","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00296-023-05435-x","volume":"43","author":"D Bekaryssova","year":"2023","unstructured":"Bekaryssova D, Yessirkepov M, Mahmudov K (2023) Structure, demography, and medico-social characteristics of articular syndrome in rheumatic diseases: a retrospective monocentric analysis of 2019\u20132021 data. Rheumatol Int 43:2057\u20132064. https:\/\/doi.org\/10.1007\/s00296-023-05435-x","journal-title":"Rheumatol Int"},{"key":"5651_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","volume":"166","author":"CS Crowson","year":"2013","unstructured":"Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, Hlatky MA, Gabriel SE (2013) Rheumatoid arthritis and cardiovascular disease. Am Heart J 166:622\u2013628e1. https:\/\/doi.org\/10.1016\/j.ahj.2013.07.010","journal-title":"Am Heart J"},{"key":"5651_CR8","doi-asserted-by":"publisher","unstructured":"Bannon M (ed) (2011) Editor\u2019s choice: cardiovascular disease and rheumatoid arthritis. QJM 104:1\u20132. https:\/\/doi.org\/10.1093\/qjmed\/hcq246","DOI":"10.1093\/qjmed\/hcq246"},{"key":"5651_CR9","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.ijcard.2012.05.057","volume":"167","author":"S Corrao","year":"2013","unstructured":"Corrao S, Messina S, Pistone G, Calvo L, Scaglione R, Licata G (2013) Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol 167:2031\u20132038. https:\/\/doi.org\/10.1016\/j.ijcard.2012.05.057","journal-title":"Int J Cardiol"},{"key":"5651_CR10","doi-asserted-by":"publisher","unstructured":"Dessein PH, Semb AG, Gonz\u00e1lez-Gay MA, Popa CD (2015) Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management. Biomed Res Int 2015(850671). https:\/\/doi.org\/10.1155\/2015\/850671","DOI":"10.1155\/2015\/850671"},{"key":"5651_CR11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1136\/annrheumdis-2013-203911","volume":"72","author":"PH Dessein","year":"2013","unstructured":"Dessein PH, Semb AG (2013) Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced? Ann Rheum Dis 72:1743\u20131746. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203911","journal-title":"Ann Rheum Dis"},{"key":"5651_CR12","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/art.42236","volume":"74","author":"SL Bridges","year":"2022","unstructured":"Bridges SL, Jr, Niewold TB, Merriman TR (2022) Is rheumatoid arthritis a causal factor in Cardiovascular Disease? Arthritis Rheumatol 74:1612\u20131614. https:\/\/doi.org\/10.1002\/art.42236","journal-title":"Arthritis Rheumatol"},{"key":"5651_CR13","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.molmed.2022.10.007","volume":"28","author":"JM Gelfand","year":"2022","unstructured":"Gelfand JM, Wang S, Garshick MS (2022) Autoimmune diseases and cardiovascular risk. Rends Mol Med 28:1025\u20131027. https:\/\/doi.org\/10.1016\/j.molmed.2022.10.007","journal-title":"Rends Mol Med"},{"key":"5651_CR14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s12265-020-09964-9","volume":"13","author":"J Halacoglu","year":"2020","unstructured":"Halacoglu J, Shea LA (2020) Cardiovascular Risk Assessment and therapeutic implications in rheumatoid arthritis. J Cardiovasc Transl Res 13:878\u2013890. https:\/\/doi.org\/10.1007\/s12265-020-09964-9","journal-title":"J Cardiovasc Transl Res"},{"key":"5651_CR15","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s10067-020-04937-4","volume":"39","author":"M Azeez","year":"2020","unstructured":"Azeez M, Clancy C, O\u2019Dwyer T, Lahiff C, Wilson F, Cunnane G (2020) Benefits of exercise in patients with rheumatoid arthritis: a randomized controlled trial of a patient-specific exercise programme. Clin Rheumatol 39:1783\u20131792. https:\/\/doi.org\/10.1007\/s10067-020-04937-4","journal-title":"Clin Rheumatol"},{"key":"5651_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3899\/jrheum.201415","volume":"48","author":"JM Kremer","year":"2021","unstructured":"Kremer JM (2021) Methotrexate and Cardiovascular Disease in patients with rheumatoid arthritis: insights and Novel speculations. J Rheumatol 48:793\u2013795. https:\/\/doi.org\/10.3899\/jrheum.201415","journal-title":"J Rheumatol"},{"key":"5651_CR17","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.2174\/138161212799504795","volume":"18","author":"WM Mellana","year":"2012","unstructured":"Mellana WM, Aronow WS, Palaniswamy C, Khera S (2012) Rheumatoid arthritis: cardiovascular manifestations, pathogenesis, and therapy. Curr Pharm Des 18:1450\u20131456. https:\/\/doi.org\/10.2174\/138161212799504795","journal-title":"Curr Pharm Des"},{"key":"5651_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.biopha.2006.09.006","volume":"60","author":"MA Gonzalez-Gay","year":"2006","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Garcia-Porrua C, Llorca J, Martin J (2006) Cardiovascular disease in rheumatoid arthritis. Biomed Pharmacother 60:673\u2013677. https:\/\/doi.org\/10.1016\/j.biopha.2006.09.006","journal-title":"Biomed Pharmacother"},{"key":"5651_CR19","doi-asserted-by":"publisher","first-page":"e1800013","DOI":"10.1002\/adhm.201800013","volume":"7","author":"Y Lu","year":"2018","unstructured":"Lu Y, Li L, Lin Z, Wang L, Lin L, Li M et al (2018) A new treatment modality for rheumatoid arthritis: combined photothermal and photodynamic therapy using cus nanoparticles. Adv Healthc Mater 7:e1800013. https:\/\/doi.org\/10.1002\/adhm.201800013","journal-title":"Adv Healthc Mater"},{"key":"5651_CR20","doi-asserted-by":"publisher","first-page":"586665","DOI":"10.3389\/fmed.2020.586665","volume":"7","author":"X Ye","year":"2020","unstructured":"Ye X, Chen Z, Shen Z, Chen G, Xu X (2020) Yoga for treating rheumatoid arthritis: a systematic review and Meta-analysis. Front Med (Lausanne) 7:586665. https:\/\/doi.org\/10.3389\/fmed.2020.586665","journal-title":"Front Med (Lausanne)"},{"key":"5651_CR21","doi-asserted-by":"publisher","first-page":"1357914","DOI":"10.3389\/fmed.2024.1357914","volume":"11","author":"J Lin","year":"2024","unstructured":"Lin J, Liu J, O\u2019Fee A et al (2024) The effectiveness and safety of lifestyle medicine and integrative therapies in inflammatory arthritis: an umbrella review using a hierarchical evidence gathering approach. Front Med (Lausanne) 11:1357914. https:\/\/doi.org\/10.3389\/fmed.2024.1357914","journal-title":"Front Med (Lausanne)"},{"key":"5651_CR22","doi-asserted-by":"publisher","first-page":"101482","DOI":"10.1016\/j.berh.2019.101482","volume":"33","author":"AA K\u00fc\u00e7\u00fckdeveci","year":"2019","unstructured":"K\u00fc\u00e7\u00fckdeveci AA (2019) Nonpharmacological treatment in established rheumatoid arthritis. Best practice & research. Best Pract Res Clin Rheumatol 33:101482. https:\/\/doi.org\/10.1016\/j.berh.2019.101482","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5651_CR23","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3390\/jpm12111905","volume":"12","author":"L Slagter","year":"2022","unstructured":"Slagter L, Demyttenaere K, Verschueren P, De Cock D (2022) The Effect of Meditation, Mindfulness, and yoga in patients with rheumatoid arthritis. J Pers Med 12:1905. https:\/\/doi.org\/10.3390\/jpm12111905","journal-title":"J Pers Med"},{"key":"5651_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.berh.2019.03.013","volume":"32","author":"GS Metsios","year":"2018","unstructured":"Metsios GS, Kitas GD (2018) Physical activity, exercise and rheumatoid arthritis: effectiveness, mechanisms and implementation. Best Pract Res Clin Rheumatol 32:669\u2013682. https:\/\/doi.org\/10.1016\/j.berh.2019.03.013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5651_CR25","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.41752","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR et al (2021) 2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 73:1108\u20131123. https:\/\/doi.org\/10.1002\/art.41752","journal-title":"Arthritis Rheumatol"},{"key":"5651_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/rheumatology\/kem260","volume":"47","author":"GS Metsios","year":"2008","unstructured":"Metsios GS, Stavropoulos-Kalinoglou A, van Veldhuijzen JJ et al (2008) Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology (Oxford) 47:239\u2013248. https:\/\/doi.org\/10.1093\/rheumatology\/kem260","journal-title":"Rheumatology (Oxford)"},{"key":"5651_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.reuma.2016.04.003","volume":"13","author":"MV Hern\u00e1ndez-Hern\u00e1ndez","year":"2017","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez MV, D\u00edaz-Gonz\u00e1lez F (2017) Role of physical activity in the management and assessment of rheumatoid arthritis patients. Reumatol Clin 13:214\u2013220. https:\/\/doi.org\/10.1016\/j.reuma.2016.04.003","journal-title":"Reumatol Clin"},{"key":"5651_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/acr.23589","volume":"71","author":"E Lange","year":"2019","unstructured":"Lange E, Kucharski D, Svedlund S et al (2019) Effects of Aerobic and Resistance Exercise in older adults with rheumatoid arthritis: a Randomized Controlled Trial. Arthritis Care Res (Hoboken) 71:61\u201370. https:\/\/doi.org\/10.1002\/acr.23589","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5651_CR29","doi-asserted-by":"publisher","first-page":"1089621","DOI":"10.3389\/fimmu.2022.1089621","volume":"13","author":"Z Li","year":"2023","unstructured":"Li Z, Wang XQ (2023) Clinical effect and biological mechanism of exercise for rheumatoid arthritis: a mini review. Front Immunol 13:1089621. https:\/\/doi.org\/10.3389\/fimmu.2022.1089621","journal-title":"Front Immunol"},{"key":"5651_CR30","doi-asserted-by":"publisher","first-page":"e25019","DOI":"10.1097\/MD.0000000000025019","volume":"100","author":"Z Wen","year":"2021","unstructured":"Wen Z, Chai Y (2021) Effectiveness of resistance exercises in the treatment of rheumatoid arthritis: a meta-analysis. Med (Baltim) 100:e25019. https:\/\/doi.org\/10.1097\/MD.0000000000025019","journal-title":"Med (Baltim)"},{"key":"5651_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jan.14574","volume":"77","author":"H Hu","year":"2021","unstructured":"Hu H, Xu A, Gao C, Wang Z, Wu X (2021) The effect of physical exercise on rheumatoid arthritis: an overview of systematic reviews and meta-analysis. J Adv Nurs 77:506\u2013522. https:\/\/doi.org\/10.1111\/jan.14574","journal-title":"J Adv Nurs"},{"key":"5651_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2016.11.009","volume":"256","author":"R Gualtierotti","year":"2017","unstructured":"Gualtierotti R (2017) Understanding cardiovascular risk in rheumatoid arthritis: still a long way to go. Atherosclerosis 256:123\u2013124. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.11.009","journal-title":"Atherosclerosis"},{"key":"5651_CR33","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s00296-023-05459-3","volume":"43","author":"D Bekaryssova","year":"2023","unstructured":"Bekaryssova D, Mruthyunjaya Vijaya P, Ahmed S, Sondur S, Zimba O (2023) Revisiting articular syndrome in the peri-pandemic COVID-19 era. Rheumatol Int 43:2157\u20132166. https:\/\/doi.org\/10.1007\/s00296-023-05459-3","journal-title":"Rheumatol Int"},{"key":"5651_CR34","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00296-023-05343-0","volume":"43","author":"M Yessirkepov","year":"2023","unstructured":"Yessirkepov M, Bekaryssova D, Mutalipova G, Narkabulov A (2023) Trends in the incidence of musculoskeletal diseases in Kazakhstan in 2011\u20132020: an information-analytical study. Rheumatol Int 43:1541\u20131545. https:\/\/doi.org\/10.1007\/s00296-023-05343-0","journal-title":"Rheumatol Int"},{"key":"5651_CR35","first-page":"460","volume":"21","author":"M Adawi","year":"2019","unstructured":"Adawi M, Firas S, Blum A (2019) Rheumatoid arthritis and atherosclerosis. Isr Med Assoc J 21:460\u2013463","journal-title":"Isr Med Assoc J"},{"key":"5651_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/157016108784911975","volume":"6","author":"JF Boyer","year":"2008","unstructured":"Boyer JF, Cantagrel A, Constantin A (2008) Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis. Curr Vasc Pharmacol 6:218\u2013227. https:\/\/doi.org\/10.2174\/157016108784911975","journal-title":"Curr Vasc Pharmacol"},{"key":"5651_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10354-005-0242-9","volume":"156","author":"L Carroll","year":"2006","unstructured":"Carroll L, Hannawi S, Marwick T, Thomas R (2006) Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end products. Wien Med Wochenschr 156:42\u201352. https:\/\/doi.org\/10.1007\/s10354-005-0242-9","journal-title":"Wien Med Wochenschr"},{"key":"5651_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/msc.1196","volume":"16","author":"K Ladak","year":"2018","unstructured":"Ladak K, Hashim J, Clifford-Rashotte M, Tandon V, Matsos M, Patel A (2018) Cardiovascular risk management in rheumatoid arthritis: a large gap to close. Musculoskelet Care 16:152\u2013157. https:\/\/doi.org\/10.1002\/msc.1196\u0441","journal-title":"Musculoskelet Care"},{"key":"5651_CR39","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41440-020-0483-4","volume":"43","author":"S Hannawi","year":"2020","unstructured":"Hannawi S, Hannawi H, Al Salmi I (2020) Cardiovascular disease and subclinical atherosclerosis in rheumatoid arthritis. Hypertens Res 43:982\u2013984. https:\/\/doi.org\/10.1038\/s41440-020-0483-4","journal-title":"Hypertens Res"},{"key":"5651_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41927-018-0014-y","volume":"2","author":"A Jagpal","year":"2018","unstructured":"Jagpal A, Navarro-Mill\u00e1n I (2018) Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment. BMC Rheumatol 2:10. https:\/\/doi.org\/10.1186\/s41927-018-0014-y","journal-title":"BMC Rheumatol"},{"key":"5651_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2004.11.016","volume":"180","author":"H Ohta","year":"2005","unstructured":"Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Fujii H, Saito K, Sekikawa K, Seishima M (2005) Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 180:11\u201317. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.11.016","journal-title":"Atherosclerosis"},{"key":"5651_CR42","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.autrev.2016.07.026","volume":"15","author":"R L\u00f3pez-Mej\u00edas","year":"2016","unstructured":"L\u00f3pez-Mej\u00edas R, Casta\u00f1eda S, Gonz\u00e1lez-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, Remuzgo-Mart\u00ednez S, Rodriguez-Rodriguez L, Blanco R, Llorca J, Mart\u00edn J, Gonz\u00e1lez-Gay MA (2016) Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun Rev 15:1013\u20131030. https:\/\/doi.org\/10.1016\/j.autrev.2016.07.026","journal-title":"Autoimmun Rev"},{"key":"5651_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/1744666X.2021.1899809","volume":"17","author":"GA Karpouzas","year":"2021","unstructured":"Karpouzas GA, Bui VL, Ronda N, Hollan I, Ormseth SR (2021) Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: a review of evidence and mechanistic insights. Expert Rev Clin Immunol 17:355\u2013374. https:\/\/doi.org\/10.1080\/1744666X.2021.1899809","journal-title":"Expert Rev Clin Immunol"},{"key":"5651_CR44","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3390\/jcm11102704","volume":"11","author":"B Dijkshoorn","year":"2022","unstructured":"Dijkshoorn B, Raadsen R, Nurmohamed MT (2022) Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022. J Clin Med 11:2704. https:\/\/doi.org\/10.3390\/jcm11102704","journal-title":"J Clin Med"},{"key":"5651_CR45","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","volume":"361","author":"BR England","year":"2018","unstructured":"England BR, Thiele GM, Anderson DR, Mikuls TR (2018) Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ 361:k1036. https:\/\/doi.org\/10.1136\/bmj.k1036","journal-title":"BMJ"},{"key":"5651_CR46","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","volume":"81","author":"GC Drosos","year":"2022","unstructured":"Drosos GC, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S, Boumpas DT, Brodin N, Bruce IN, Gonz\u00e1lez-Gay M\u00c1, Jacobsen S, Kerekes G, Marchiori F, Mukhtyar C et al (2022) EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis 81:768\u2013779. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221733","journal-title":"Ann Rheum Dis"},{"key":"5651_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.38210","volume":"66","author":"I del Rinc\u00f3n","year":"2014","unstructured":"del Rinc\u00f3n I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A (2014) Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol 66:264\u2013272. https:\/\/doi.org\/10.1002\/art.38210","journal-title":"Arthritis Rheumatol"},{"key":"5651_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11926-017-0643-y","volume":"19","author":"AM Chodara","year":"2017","unstructured":"Chodara AM, Wattiaux A, Bartels CM (2017) Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: clinical updates and three strategic approaches. Curr Rheumatol Rep 19:16. https:\/\/doi.org\/10.1007\/s11926-017-0643-y","journal-title":"Curr Rheumatol Rep"},{"key":"5651_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.berh.2015.09.003","volume":"29","author":"JT Giles","year":"2015","unstructured":"Giles JT (2015) Cardiovascular disease in rheumatoid arthritis: current perspectives on assessing and mitigating risk in clinical practice. Best Pract Res Clin Rheumatol 29:597\u2013613. https:\/\/doi.org\/10.1016\/j.berh.2015.09.003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5651_CR50","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1089\/acm.2019.0228","volume":"26","author":"S Ganesan","year":"2020","unstructured":"Ganesan S, Gaur GS, Negi VS, Sharma VK, Pal GK (2020) Effect of yoga therapy on Disease Activity, inflammatory markers, and Heart Rate Variability in patients with rheumatoid arthritis. J Altern Complement Med 26:501\u2013507. https:\/\/doi.org\/10.1089\/acm.2019.0228","journal-title":"J Altern Complement Med"},{"key":"5651_CR51","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.3390\/ijerph19106102","volume":"19","author":"I Biswas","year":"2022","unstructured":"Biswas I, Lewis S, Chattopadhyay K (2022) Content, structure and delivery characteristics of yoga interventions for managing rheumatoid arthritis: a systematic review protocol. Int J Environ Res Public Health 19:6102. https:\/\/doi.org\/10.3390\/ijerph19106102","journal-title":"Int J Environ Res Public Health"},{"key":"5651_CR52","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3389\/fpsyg.2020.02259","volume":"11","author":"S Gautam","year":"2020","unstructured":"Gautam S, Kumar M, Kumar U, Dada R (2020) Effect of an 8-Week yoga-based lifestyle intervention on Psycho-Neuro-Immune Axis, Disease Activity, and Perceived Quality of Life in Rheumatoid Arthritis patients: a Randomized Controlled Trial. Front Psychol 11:2259. https:\/\/doi.org\/10.3389\/fpsyg.2020.02259","journal-title":"Front Psychol"},{"key":"5651_CR53","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1111\/1756-185X.14874","volume":"26","author":"A Mooventhan","year":"2023","unstructured":"Mooventhan A, Pavithra, Meha N et al (2023) A comprehensive scientific evidence-based impact of yoga in patients with rheumatoid arthritis. Int J Rheum Dis 26:2359\u20132365. https:\/\/doi.org\/10.1111\/1756-185X.14874","journal-title":"Int J Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05651-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05651-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05651-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T02:04:21Z","timestamp":1724465061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05651-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["5651"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05651-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Local Ethics Committee at South Kazakhstan Medical Academy, Protocol \u21161.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for additional written informed consent was waived because of the retrospective design of this study and the use of anonymous patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have stated that there are no conflicts of interest in connection with this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}